1. Home
  2. ETJ vs EYPT Comparison

ETJ vs EYPT Comparison

Compare ETJ & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

ETJ

Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.66

Market Cap

592.9M

Sector

Finance

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.83

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETJ
EYPT
Founded
2007
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
592.9M
1.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
ETJ
EYPT
Price
$8.66
$16.83
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$29.60
AVG Volume (30 Days)
175.6K
1.1M
Earning Date
01-01-0001
11-05-2025
Dividend Yield
8.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$42,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.20
$3.91
52 Week High
$8.47
$19.11

Technical Indicators

Market Signals
Indicator
ETJ
EYPT
Relative Strength Index (RSI) 42.24 62.56
Support Level $8.63 $15.81
Resistance Level $8.84 $19.11
Average True Range (ATR) 0.09 0.94
MACD -0.01 0.02
Stochastic Oscillator 2.15 54.55

Price Performance

Historical Comparison
ETJ
EYPT

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: